Company intelligence / Profile preview

FEI Company

Hillsboro, Oregon, United States

Ownership: Private
Employees: ~3000
Development stage: Other

Overview

FEI provided cryo-EM technology and electron microscopy solutions for structural biology and drug discovery research. The company's Cryo-EM systems enabled researchers to obtain three-dimensional molecular structures and analyze protein-based molecular machines at atomic resolution.

Modalities: Device (electron microscopy equipment)
Industry: Pathology

Partnerships

Cambridge Pharmaceutical Cryo-EM Consortium (partnership with Astex Pharmaceuticals, AstraZeneca, GlaxoSmithKline, Heptares Therapeutics, UCB, Medical Research Council Laboratory of Molecular Biology, and University of Cambridge's Nanoscience Centre)

Beyond the preview

Go deeper on FEI Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FEI Company.

Explore the full profile